ARCH Venture Fund XII, L.P.
Related Filers (8)
- Neumora Therapeutics, Inc. (11)
- ARCH Venture Partners XII, L.P. (9)
- ARCH Venture Partners XII, LLC (9)
- CRANDELL KEITH (9)
- GILLIS STEVEN (9)
- NELSEN ROBERT (9)
- BYBEE CLINTON (3)
- ARCH Venture Partners X, LLC (2)
- Show More ...
Other (2)
D/A
Friday, 4/1/2022
Exempt (Private) Offering
D
Thursday, 2/3/2022
Exempt (Private) Offering
Ownership (11)
SC 13D/A
Friday, 12/15/2023
Neumora Therapeutics, Inc.: Major Shareholders
4
Tuesday, 12/12/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/15/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/13/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/7/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 10/2/2023
Neumora Therapeutics, Inc.: Major Shareholders
4
Friday, 9/29/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/27/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/25/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/20/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/14/2023
Neumora Therapeutics, Inc.: Initial statement of beneficial ownership of securities